Carson Wealth (CWM LLC)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22	Closed	–	–	5308
2024 Q2	$0	Buy	22 +17	+340%	+$252	﹤0.01%	5096
2024 Q1	$0	Buy	+5	New	+$70	﹤0.01%	4895
2023 Q3	–	Sell	-275	Closed	-$3K	–	4683
2023 Q2	$3K	Buy	+275	New	+$3.44K	﹤0.01%	3734

Carson Wealth (CWM LLC)'s MACK Position: Q3 2024 in Review

Carson Wealth (CWM LLC) sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2024, closing a stake of 22 shares.

Carson Wealth (CWM LLC) first reported a position in MACK in Q2 2023 and held it in 3 quarters. The position peaked at $3K in Q2 2023. 2 funds tracked by Wall St. Rank hold MACK as of Q3 2024.

Carson Wealth (CWM LLC) reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 22 Merrimack Pharmaceuticals, Inc. shares in Q3 2024.
Carson Wealth (CWM LLC) first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2023 and held it in 3 quarters.
Carson Wealth (CWM LLC)'s Merrimack Pharmaceuticals, Inc. position peaked at $3K in Q2 2023.
2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.